# Sonnest

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sonnest

- Industry: Medical Devices & Equipment
- Headquarters: Philadelphia, US
- Website: www.sonnest.com
- Total disclosed funding: $4M
- Latest round: Series A (May 26, 2021)
- Investors on record: 3

## About

Sonnest, Inc. specializes in providing digital solutions that enhance online presence and streamline business operations for small to medium-sized enterprises, helping them effectively navigate the online landscape.Sonnest, Inc. was founded by Andrew Kohut, Brett Angel, and Michael Cimorelli, with Josh White serving as the CEO. The company is headquartered in Philadelphia, US, and focuses on digital services tailored for SMEs. In May 2021, Sonnest, Inc. raised USD 4 mn in Series A funding, led by Robin Hood Ventures, SWAN Impact, and Texas Halo Fund.Sonnest, Inc. offers a comprehensive suite of digital solutions, including web hosting services, domain registration, and website building tools. These offerings are designed to assist small to medium-sized enterprises in establishing their digital presence, addressing website accessibility, online marketing, and customer engagement issues. The company serves a broad client base, including entrepreneurs, small business owners, and e-commerce operators across North America, Europe, and Asia-Pacific regions.Sonnest, Inc. generates revenue through a structured model that combines subscription services and one-time fees. Clients typically subscribe to annual or monthly web hosting and related services, with optional add-ons such as premium support. The firm operates a direct-to-consumer model, allowing customers to purchase services from its website, with flagship products including web hosting packages and domain registration services offered at tiered pricing levels to accommodate diverse customer needs.Following the Series A funding round in May 2021, Sonnest, Inc. intends to utilize the USD 4 mn raised to advance its product offerings, specifically the Electrast™ technology. The company aims to move Electrast™ into clinical settings, focusing on confirming its safety profile and generating proof-of-principle ultrasound images in human patients, akin to previous demonstrations in other animal models. These initiatives are part of Sonnest's strategy to enhance its product lineup and expand its market reach.

## Funding rounds

- Series A, May 26, 2021, $4M — Robin Hood Ventures, Texas Halo Fund, SWAN Impact

## Investors

- Robin Hood Ventures (https://capitalatlas.ai/funds/robin-hood-ventures) — Series A
- Texas Halo Fund (https://capitalatlas.ai/funds/texas-halo-fund) — Series A
- SWAN Impact — Series A